LicianPro

Apimeds Pharmaceuticals US, Inc. ·

APUS 8-K 2026-09-29

Apimeds Pharmaceuticals US, Inc. (APUS) 8-K dated 2026-09-29 — accession 0001213900-26-104668.

Apimeds Pharmaceuticals US, Inc. (APUS) is a drug manufacturers - specialty & generic company listed on US.

Apimeds Pharmaceuticals US, Inc. filed a 8-K on 2026-09-29. Accession 0001213900-26-104668.

This 8-K covers: Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for APUS is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The APUS SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr